Advances in Chronic Kidney Disease
Volume 12, Issue 3 , Pages 312-325 , July 2005

Use of Alternative Medicine by Patients With Stage 5 Chronic Kidney Disease

  • Jerrilynn D. Burrowes

      Affiliations

    • C.W. Post Campus of Long Island University, School of Health Professions and Nursing, Department of Nutrition, Brookville, NY
    • Corresponding Author InformationAddress correspondence to Jerrilynn D. Burrowes, PhD, RD, C.W. Post Campus of Long Island University, School of Health Professions and Nursing, Department of Nutrition, 720 Northern Blvd, Brookville, NY 11548.
    • ,
  • Gloria Van Houten

      Affiliations

    • St. Catherine of Siena Medical Center, The Center for Renal Disease, Smithtown, NY

References 

  1. Institute of Medicine of the National Academies: Complementary and alternative medicine (CAM) in the United States. Available at: http://www.nap.edu/books/0309092701/html. Accessed January 23, 2005.
  2. Barnes PM , Powell-Griner E , McFann K , et al.   Complementary and Alternative Medicine Use Among Adults: United States, 2002. Advance Data From Vital and Health Statistics no 343 . Hyattsville, MD: National Center for Health Statistics; 2004;
  3. Fragakis AS . The Health Professional’s Guide to Popular Dietary Supplements . (ed 2). Chicago, IL: American Dietetic Association; 2003;
  4. White House Commission on Complementary and Alternative Medicine Policy. Final Report: White House Commission on complementary and alternative medicine policy . 2002; Washington, DC
  5. Eisenberg DM , Davis RB , Ettner SL , et al.   Trends in alternative medicine use in the United States, 1990–1997 (Results of a follow-up national survey) . JAMA . 1998;280:1569–1575
  6. Slesinski MJ , Subar AF , Kahle LL . Trends in use of vitamin and mineral supplements in the Unites States (The 1987 and 1992 National Health Interview Surveys) . J Am Diet Assoc . 1995;95:921–923
  7. Druss BG , Rosenbeck RA . Association between use of unconventional therapies and conventional medical services . JAMA . 1999;282:651–656
  8. Astin JA . Why patients use alternative medicine (Results of a national study) . JAMA . 1998;279: 1548–1543
  9. Food and Drug Administration: Dietary Supplement Health and Education Act of 1994. Available at: http://vm.cfsan.fda.gov/∼dms/dietsuppl.html. Accessed January 23, 2005.
  10. Kleshinski FG , Crews C , Fry E , et al.   A survey of herbal product use in a dialysis population in northwest Ohio . J Renal Nutr . 2003;13:93–97
  11. Dahl NV . Herbs and supplements in dialysis patients (Panacea or poison?) . Semin Dial . 2001;14:186–192
  12. Chow J . Probiotics and prebiotics (A brief overview) . J Renal Nutr . 2002;12:76–86
  13. Jellin JM , Gregory PJ , Batz F , et al.   In: Pharmacist’s Letter/Prescriber’s Letter Natural Medicines Comprehensive Database . (ed 4). Stockton, CA: Therapeutic Research Faculty; 2002;p. 131–1384
  14. Simenhoff ML , Dunn SR , Zoliner GP , et al.   Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus . Miner Electro Metab . 1996;22:92–96
  15. Hida M , Aiba Y , Sawamura S , et al.   Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacterial preparation, to uremic patients undergoing hemodialysis . Nephron . 1996;74:349–355
  16. Liske E , Hanggi W , Henneicke-von Zepelin HH , et al.   Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizome) (A 6-month clinical study demonstrates no systemic estrogenic effect) . J Womens Health Gend Based Med . 2002;11:163–174
  17. Khan A , Safdar M , Ali Khan MM , et al.   Cinnamon improves glucose and lipids of people with type 2 diabetes . Diabetes Care . 2003;26:3215–3218
  18. Leeb BF , Schweitzer H , Montag K , et al.   A meta-analysis of chondroitin sulfate in the treatment of arthritis . J Rheumatol . 2000;27:205–211
  19. McAlindon TE , LaValley MP , Gulin JP , et al.   Glucosamine and chondroitin for treatment of osteoarthritis (A systematic quality assessment and meta-analysis) . JAMA . 2000;283:1469–1475
  20. Uebellhart D , Malaise M , Marcologo R , et al.   Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate (A one-year, randomized, double-blind, multicenter study versus placebo) . Osteoarth Cartil . 2004;12:269–276
  21. Folkers K , Langsjoen P , Willis R , et al.   Lovastatin decreases coenzyme Q levels in humans . Proc Natl Acad Sci U S A . 1990;87:8931–8934
  22. Brinkeborn RM , Shah DV , Degenring FH . Echinaforce and other echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled double-blind clinical trial . Phytomedicine . 1999;6:1–6
  23. Giles JT , Palat CT , Chien SH , et al.   Evaluation of Echinacea for treatment of the common cold . Pharmacotherapy . 2000;20:690–697
  24. Grimm W , Muller HH . A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections . Am J Med . 1999;106:138–143
  25. Ernst E . The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s Wort, ginseng, echinacea, saw palmetto, and kava . Ann Intern Med . 2002;136:42–53
  26. Melchart D , Linde K , Worku R , et al.   Immunomodulation with Echinacea—A systematic review of controlled clinical trials . Phytomedicine . 1994;1:245–254
  27. Hsu HC , Lee YT , Chen MF . Effect of n-3 fatty acids on the composition and binding properties of lipoproteins in hypertriglyceridemic patients . Am J Clin Nutr . 2000;71:28–35
  28. Roche HM , Gibney MJ . Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triaclyglycerol metabolism . Am J Clin Nutr . 2000;71(suppl):228S–231S
  29. Santos J , Queiros J , Silva F , et al.   Effects of fish oil in cyclosporine-treated renal transplant recipients . Transplant Proc . 2000;32:2605–2608
  30. Schmitz P , McCloud L , Reikes S , et al.   Prophylaxis of hemodialysis graft thrombosis with fish oil (Double-blind, randomized, prospective trial) . J Am Soc Nephrol . 2002;13:184–190
  31. Vergili-Nelsen JM . Benefits of fish oil supplementation for hemodialysis patients . J Am Diet Assoc . 2003;103:1174–1177
  32. Morris MC , Sacks F , Rosner B . Does fish oil lower blood pressure? A meta-analysis of controlled trials . Circulation . 1993;88:523–533
  33. Toft I , Bonaa H , Ingebretsen OC , et al.   Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial . Ann Intern Med . 1995;123:911–918
  34. Sacks FM , Hebert P , Appel LJ , et al.   The effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention . J Hypertens . 1994;12:209–213
  35. Vondongen R , Mori TA , Burke V , et al.   Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease . Hypertension . 1993;22:371–379
  36. Zhao G , Etherton TD , Martin KR , et al.   Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women . J Nutr . 2004;134:2991–2997
  37. Stevinson C , Pittler MH , Ernst E . Garlic for treating hypercholesterolemia (A meta-analysis of randomized clinical trials) . Ann Int Med . 2000;133:420–429
  38. Warshafsky S , Kamer RR , Sivak SL . Effect of garlic on total serum cholesterol (A meta-analysis) . Ann Intern Med . 1993;119:599–605
  39. Kannar D , Wattanapenpaiboon N , Savige GS , et al.   Hypocholesterolemic effect of an enteric-coated garlic supplement . J Am Coll Nutr . 2001;20:225–231
  40. Neil HA , Silagy CA , Lancaster T , et al.   Garlic powder in the treatment of moderate hypelipidemia (A controlled trial and meta-analysis) . J R College Physicians Lond . 1996;30:329–334
  41. Berthold HK , Sudhop T , von Bergmann K . Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism (A randomized controlled trial) . JAMA . 1998;279:1900–1902
  42. Silagy CA , Neil HA . A meta-analysis of the effect of garlic on blood pressure . J Hypertens . 1994;12:463–468
  43. Oken BS , Storzbach DM , Kaye JA . The efficacy of Gingko biloba on cognitive function in Alzheimer disease . Arch Neurol . 1998;55:1409–1415
  44. Vuksan V , Sievenpiper JL , Koo VYY , et al.   American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus . Arch Intern Med . 2000;160:1009–1013
  45. Wesnes KA , Ward T , McGinty A , et al.   The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers . Psychopharmacology . 2000;152:353–361
  46. D’Angelo L , Grimaldi R , Caravaggi M , et al.   A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers . J Ethnopharmacol . 1986;16:15–22
  47. Bushman JL . Green tea and cancer in humans (a review of the literature) . Nutr Cancer . 1998;31:151–159
  48. Fujiki H , Suganuma M , Okabe S , et al.   Mechanistic findings of green tea as cancer preventive for humans . Proc Soc Exp Bio Med . 1999;220:225–228
  49. Pisters KM , Newman RA , Coldman B , et al.   Phase I trial of oral green tea extract in adult patients with solid tumors . J Clin Oncol . 2001;19:1830–1838
  50. Serra A , Uehlinger DE , Ferrari P , et al.   Gycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria . J Am Soc Nephrol . 2002;13:191–196
  51. Hinoshita F , Ogura Y , Suziku Y , et al.   Effect of orally administered Shao-Yao-Gan-Cao-Tang (Shakuyaku-kanzo-to) on muscle cramps in maintenance hemodialysis patients (A preliminary study) . Am J Chin Med . 2003;31:445–453
  52. Brown L , Rimm EB , Seddon JM , et al.   A prospective study of carotenoid intake and risk of cataract extraction in U.S. men . Am J Clin Nutr . 1999;70:517–524
  53. Chassan-Taber L , Willet WC , Seddon JM , et al.   A prospective study of carotenoid and vitamin A intake and risk of cataract extraction in U.S. women . Am J Clin Nutr . 1999;70:509–516
  54. University of Maryland Medical Center/Complementary Medicine: Milk thistle. Available at: http://www.umm.edu/altmed/ConsHerbs/MilkThistlech.html. Accessed January 25, 2005.
  55. Mueller BA , Scott MK , Sowinski M , et al.   Noni juice (Morinda citrifolia) (Hidden potential for hyperkalemia?) . Am J Kidney Dis . 2000;35:310–312
  56. Marks LS , Partin AW , Epstein JL , et al.   Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hypertrophy . J Urol . 2000;163:1451–1456
  57. Linde K , Ramirez G , Mulrow CD . St. John’s wort for depression: An overview and meta-analysis of randomized clinical trials . BMJ . 1996;313:253–258
  58. Kim HL , Streltzer J , Goebert D . St. John’s wort for depression: A meta-analysis of well-defined clinical trials . J Nerv Ment Dis . 1999;187:532–539
  59. Schrader E . Equivalence of St. John’s wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression . Int Clin Psychopharmacol . 2000;15:61–68
  60. Beckman SE , Sommi RW , Switzer J . Consumer use of St. John’s wort: A survey on effectiveness, safety, and tolerability . Pharmacotherapy . 2000;20:568–574
  61. Dean AJ , Moses GM , Vernon JM . Suspected withdrawal syndrome after cessation of St Johns Wort . Ann Pharmacother . 2003;37:150
  62. Mai I , Kruger H , Budde K , et al.   Hazardous pharamacokinetic interaction of St. John’s wort (Hypericum perforatum) with the immunosuppressant cyclosporin . Int J Clin Pharmacol Ther . 2000;38:500–502
  63. Barone GW , Gurley BJ , Ketel BL , et al.   Drug interaction between St. John’s wort and cyclosporine . Ann Pharmacother . 2000;34:1014–1016
  64. Duncan MG . The effects of nutritional supplements on the treatment of depression, diabetes, and hypercholesterolemia in the renal patient . J Renal Nutr . 1999;9:58–62
  65. Fishbane S , Frei GL , Finger M , et al.   Hypervitaminosis A in two hemodialysis patients . Am J Kidney Dis . 1995;25:346–349
  66. Farley D: Dietary supplements: making sure hype doesn’t overwhelm science. Available at: http://www.fda.gov/bbs/topics/consumer/con00259.html. Accessed December 10, 2004.
  67. Food and Drug Administration: Illnesses and injuries associated with the use of selected dietary supplements. Available at: http://www.cfsan.fda.gov/∼dms/ds-ill.html. Accessed December 10, 2004.
  68. Age-Related Eye Disease Study Research Group . A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 . Arch Ophthamol . 2001;119:1417–1436
  69. Tardif JC , Cote G , Lesperance J , et al.   Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group . N Engl J Med . 1997;337:365–372
  70. Brown BG , Zhao XQ , Chait A , et al.   Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease . N Engl J Med . 2001;345:1583–1592
  71. Tremblay R , Bonnardeaux A , Geadah D , et al.   Hyperhomocysteinemia in hemodialysis patients (Effects of 12-month supplementation with hydrosoluble vitamins) . Kidney Int . 2000;58:851–858
  72. McKinley MC , McNulty H , McPartlin J , et al.   Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete . Am J Clin Nutr . 2001;73:759–764
  73. Dierkes J , Domrose U , Bosselmann KP , et al.   Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease . J Renal Nutr . 2001;11:67–72
  74. Okada H , Moriwaki K , Kanno Y , et al.   Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin . Nephrol Dial Transplant . 2000;15:1410–1413
  75. Baxmann AC , Mendonca COG , Heilberg IP . Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients . Kidney Int . 2003;63:1066–1071
  76. Curhan GC , Willett WC , Speizer FE , et al.   Intake of vitamins B6 and C and the risk of kidney stones in women . J Am Soc Nephrol . 1999;10:840–845
  77. Keven K , Kutlay S , Nergizoglu G , et al.   Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients . Am J Kidney Dis . 2003;41:1233–1239
  78. Hegbrant J , Hultkvist Bengtsson U . Vitamin C and E as antioxidants in hemodialysis patients . Int J Artif Organs . 1999;22:69–73
  79. Boeschoten EW , Schrijver J , Krediet RT , et al.   Deficiencies of vitamins in CAPD patients (The effect of supplementation) . Nephrol Dial Transplant . 1988;3:187–193
  80. Descombes E , Hanck AB , Fellay G . Water soluble vitamins in chronic hemodialysis patients and need for supplementation . Kidney Int . 1993;43:1319–1328
  81. Rocco MV , Makoff R . Appropriate vitamin therapy for dialysis patients . Semin Dial . 1997;10:272–277
  82. Cristol JP , Bosc JY , Badiou S , et al.   Erythropoietin and oxidative stress in haemodialysis (Beneficial effects of vitamin E supplementation) . Nephrol Dial Transplant . 1997;12:2312–2317
  83. Boaz M , Simetana S , Weinstein T , et al.   Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE) (Randomized placebo-controlled trial) . Lancet . 2000;356:1213–1218
  84. Miller ER , Pastor-Barriuso R , Dalal D , et al.   Meta-analysis (High-dosage vitamin E supplementation may increase all-cause mortality) . Ann Intern Med . 2005;142:37–46
  85. Mahajan SK , Prasad AS , Lambujon J , et al.   Improvement of uremic hypogeusia by zinc (A double-blind study) . Am J Clin Nutr . 1980;33: 1571–1521
  86. Matson A , Wright M , Oliver A , et al.   Zinc supplementation at conventional doses does not improve the disturbance of taste perception in hemodialysis patients . J Renal Nutr . 2003;13:224–228
  87. Grabe DW , Garrison GD . Comparison of natural product use between primary care and nephrology patients . Ann Pharmacother . 2004;38:1169–1172
  88. Eisenberg DM . Advising patients who seek alternative medical therapies . Ann Intern Med . 1997;127:61–69

PII: S1548-5595(05)00075-3

doi: 10.1016/j.ackd.2005.04.001

Advances in Chronic Kidney Disease
Volume 12, Issue 3 , Pages 312-325 , July 2005

Article Tools